Research Article
In Vitro and Randomized, Double-Blind, Placebo-Controlled
TrialtoDeterminetheEfficacyandSafetyofNineAntiacne
Medicinal Plants
OmarSaid ,
1
IyadKhamaysi ,
2
Abdalsalam Kmail,
3
Stephen Fulder,
1
Basheer AboFarekh,
4
RiyadAmin,
1
JamilaDaraghmeh,
3
andBasharSaad
3,4
1
Independent Researcher, Beleaf Pharma, P.O. Box 2205, Kfar Kana, Galilee 16930, Israel
2
Faculty of Medicine, Technion-ITT, Rambam Medical Center, Haifa, Israel
3
Faculty of Arts and Sciences, Arab American University Jenin, P.O. Box 240, Jenin, State of Palestine
4
Qasemi Research Center-Al-Qasemi Academy, P.O. Box 124, Baqa El-Gharbia 30100, Israel
Correspondence should be addressed to Omar Said; omar@beleafherbal.com and Bashar Saad; bashar.saad@aaup.edu
Received 28 February 2020; Revised 26 April 2020; Accepted 20 May 2020; Published 9 July 2020
Guest Editor: Xiangguo Shi
Copyright©2020OmarSaidetal.isisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
e present in vitro and randomized, double-blind, placebo-controlled trial aims to determine the efficacy and safety of nine
Mediterranean antiacne medicinal plants. e antimicrobial, antisebum, and anti-inflammatory activities of the plant extracts
were evaluated in cells from the immortalized human keratinocytes (HaCaT) and human monocytic cell line (THP-1) as well as in
a double-blind, randomized, and placebo-controlled trial. Most of the extracts showed no significant cytotoxic effects on
HaCaT cells up to 250 μg/ml. Inula helenium (IH) and Saponaria officinalis (SO) inhibited sebum production at 90 μg/ml and
30 μg/ml, respectively. e inhibition effect of SO on the growth of Cutibacterium acnes was 1.2 times higher than that of
chloramphenicol. IH and SO extracts significantly inhibited the lipopolysaccharide- (LPS-) induced IL-6 and TNF-α production
in THP-1 cells reaching the control levels of untreated cells at a concentration of 250 μg/ml. SO, IH, and Solanum nigrum (SN)
extracts inhibited the nitric oxide (NO) production in a dose-dependent manner. Based on these results, an antiacne herbal cream
(AHC) was prepared from different portions of extracts from SO, IH, and SN, and its efficacy was evaluated in a double-blind,
randomized, and controlled efficacy study with 41 acne patients, ages 18–24, who were asked to apply AHC (n � 27) or a placebo
(n � 14) two to three times daily for six weeks. Results obtained indicate that the AHC has unique synergistic effects that halt
sebum production, combined with highly antiseptic and anti-inflammatory activity, in which 54.95% (t � 19.37 P < 0.001) of acne
inflammatory and noninflammatory lesions disappeared after two weeks, 85.3%, after five weeks (t � 14.19 P < 0.001), and 91.4%,
at the end of the sixth week of application (t � 5.7 P < 0.001). In conclusion, SO, IH, and SN as single extracts and in combination
as AHC showed significant antimicrobial, antisebum, and anti-inflammatory activities in vitro and in a double-blind, randomized,
and controlled antiacne efficacy. erefore, AHC represents an interesting alternative treatment for acne.
1.Introduction
Acne, also known as acne vulgaris, is a chronic inflammatory
disease, predominantly affecting teenagers and young adults.
e currently used acne treatments target its pathogenetic
mechanisms. ese include keratinocyte hyperproliferation,
seborrhea, colonization of follicular ducts by Cutibacterium
acnes (C. acnes), and local inflammation [1–3]. Depending
on the extent and severity of the lesions, therapies vary from
topical applications of antibacterial, comedolytic, and
sebostatic medications, to systemic therapies with antibi-
otics, antiandrogenic hormones (estrogens), and retinoids
[3]. ese therapies are associated with significant side ef-
fects and thus could not be justified as a matter of course.
e immune system is chiefly responsible for coordi-
nating and regulating the disease progression and even
remission. New theories regarding acne development pro-
vide specific and rational directions for acne therapies. For
Hindawi
Evidence-Based Complementary and Alternative Medicine
Volume 2020, Article ID 3231413, 14 pages
https://doi.org/10.1155/2020/3231413